Healthcare provider profile · identity verified

Nicolas Appleton, MD

Internal Medicine · MILAN, TN · NPI 1700871480

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Lisinopril	Lisinopril	327	104
Amlodipine Besylate	Amlodipine Besylate	318	94
Atorvastatin Calcium	Atorvastatin Calcium	314	93
Pravastatin Sodium	Pravastatin Sodium	240	71
Omeprazole	Omeprazole	230	69
Gabapentin	Gabapentin	228	45
Metformin Hcl	Metformin Hcl	211	62
Levothyroxine Sodium	Levothyroxine Sodium	205	63
Metoprolol Tartrate	Metoprolol Tartrate	196	61
Clopidogrel	Clopidogrel Bisulfate	180	53
Simvastatin	Simvastatin	173	47
Rosuvastatin Calcium	Rosuvastatin Calcium	159	51
Furosemide	Furosemide	154	49
Pantoprazole Sodium	Pantoprazole Sodium	146	43
Losartan Potassium	Losartan Potassium	143	44
Alprazolam	Alprazolam	142	17
Tamsulosin Hcl	Tamsulosin Hcl	136	37
Allopurinol	Allopurinol	129	36
Tramadol Hcl	Tramadol Hcl	122	17
Metoprolol Succinate	Metoprolol Succinate	121	36
Carvedilol	Carvedilol	120	36
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	119	19
Escitalopram Oxalate	Escitalopram Oxalate	112	34
Alendronate Sodium	Alendronate Sodium	107	28
Meloxicam	Meloxicam	98	27
Potassium Chloride	Potassium Chloride	96	29
Lorazepam	Lorazepam	86	15
Hydrochlorothiazide	Hydrochlorothiazide	78	24
Albuterol Sulfate Hfa	Albuterol Sulfate	77	28
Warfarin Sodium	Warfarin Sodium	75	20
Zolpidem Tartrate	Zolpidem Tartrate	73	11
Eliquis	Apixaban	72	18
Fluticasone Propionate	Fluticasone Propionate	72	23
Glimepiride	Glimepiride	72	22
Montelukast Sodium	Montelukast Sodium	69	18
Citalopram Hbr	Citalopram Hydrobromide	68	17
Diazepam	Diazepam	61	suppressed
Trazodone Hcl	Trazodone Hcl	61	20
Duloxetine Hcl	Duloxetine Hcl	59	13
Clonazepam	Clonazepam	57	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	55	16
Lovastatin	Lovastatin	55	16
Pregabalin	Pregabalin	55	suppressed
Methylprednisolone	Methylprednisolone	54	47
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	54	16
Clonidine Hcl	Clonidine Hcl	53	13
Esomeprazole Magnesium	Esomeprazole Magnesium	50	13
Atenolol	Atenolol	46	15
Celecoxib	Celecoxib	46	16
Isosorbide Mononitrate Er	Isosorbide Mononitrate	44	14
Donepezil Hcl	Donepezil Hcl	43	suppressed
Famotidine	Famotidine	43	11
Tizanidine Hcl	Tizanidine Hcl	43	16
Levofloxacin	Levofloxacin	40	30
Azithromycin	Azithromycin	39	30
Nifedipine Er	Nifedipine	38	suppressed
Sertraline Hcl	Sertraline Hcl	37	suppressed
Ezetimibe	Ezetimibe	36	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	35	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	35	suppressed
Diclofenac Sodium	Diclofenac Sodium	34	suppressed
Spironolactone	Spironolactone	34	suppressed
Terazosin Hcl	Terazosin Hcl	34	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	33	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	33	suppressed
Hydralazine Hcl	Hydralazine Hcl	32	suppressed
Prednisone	Prednisone	31	14
Nitroglycerin	Nitroglycerin	30	15
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	30	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	30	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	29	suppressed
Meclizine Hcl	Meclizine Hcl	29	11
Digoxin	Digoxin	27	suppressed
Farxiga	Dapagliflozin Propanediol	27	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	26	20
Baclofen	Baclofen	25	suppressed
Dilt-Xr	Diltiazem Hcl	25	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	25	suppressed
Diltiazem Hcl	Diltiazem Hcl	25	suppressed
Gemfibrozil	Gemfibrozil	25	suppressed
Finasteride	Finasteride	24	suppressed
Metformin Hcl Er	Metformin Hcl	24	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	23	suppressed
Tiagabine Hcl	Tiagabine Hcl	23	suppressed
Verapamil Er	Verapamil Hcl	23	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	22	suppressed
Amiodarone Hcl	Amiodarone Hcl	21	suppressed
Buspirone Hcl	Buspirone Hcl	21	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	21	suppressed
Fenofibrate	Fenofibrate	21	suppressed
Glipizide	Glipizide	21	suppressed
Mirtazapine	Mirtazapine	21	suppressed
Acyclovir	Acyclovir	19	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	19	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	19	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	19	suppressed
Cephalexin	Cephalexin	18	13
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Ibuprofen	Ibuprofen	17	suppressed
Irbesartan	Irbesartan	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Methotrexate	Methotrexate Sodium	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	16	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	16	suppressed
Cefdinir	Cefdinir	15	suppressed
Glipizide Er	Glipizide	15	suppressed
Entresto	Sacubitril/Valsartan	14	suppressed
Nebivolol Hcl	Nebivolol Hcl	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Temazepam	Temazepam	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	suppressed
Bupropion Xl	Bupropion Hcl	13	suppressed
Divalproex Sodium	Divalproex Sodium	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Azathioprine	Azathioprine	12	suppressed
Diclofenac Sodium Er	Diclofenac Sodium	12	suppressed
Diltiazem 24hr Er (Xr)	Diltiazem Hcl	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	suppressed
Jardiance	Empagliflozin	12	suppressed
Nystatin	Nystatin	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Valsartan	Valsartan	12	suppressed
Verapamil Sr	Verapamil Hcl	12	suppressed
Depakote	Divalproex Sodium	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Ozempic	Semaglutide	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Sildenafil Citrate	Sildenafil Citrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error